WallStSmart

Braskem SA Class A (BAK)vsDow Inc (DOW)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Braskem SA Class A generates 66% more annual revenue ($70.60B vs $42.61B). DOW leads profitability with a -2.1% profit margin vs -7.8%. DOW appears more attractively valued with a PEG of 0.54. DOW earns a higher WallStSmart Score of 65/100 (C+).

BAK

Hold

48

out of 100

Grade: D+

Growth: 6.7Profit: 4.0Value: 5.3Quality: 4.5
Piotroski: 3/9Altman Z: 0.13

DOW

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 3.5Value: 5.0Quality: 4.5
Piotroski: 2/9Altman Z: 1.43
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BAK.

DOWSignificantly Overvalued (-15.3%)

Margin of Safety

-15.3%

Fair Value

$29.50

Current Price

$33.15

$3.65 premium

UndervaluedFair: $29.50Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BAK3 strengths · Avg: 9.3/10
EPS GrowthGrowth
107.2%10/10

Earnings expanding 107.2% YoY

Debt/EquityHealth
-5.4310/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
21.6%8/10

Revenue surging 21.6% year-over-year

DOW4 strengths · Avg: 9.0/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

EPS GrowthGrowth
675.0%10/10

Earnings expanding 675.0% YoY

PEG RatioValuation
0.548/10

Growing faster than its price suggests

Free Cash FlowQuality
$1.13B8/10

Generating 1.1B in free cash flow

Areas to Watch

BAK4 concerns · Avg: 2.5/10
Market CapQuality
$438.33M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-549.0%2/10

ROE of -549.0% — below average capital efficiency

Free Cash FlowQuality
$-535.00M2/10

Negative free cash flow — burning cash

DOW4 concerns · Avg: 2.5/10
Debt/EquityHealth
1.173/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-5.0%2/10

ROE of -5.0% — below average capital efficiency

Altman Z-ScoreHealth
1.432/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : BAK

The strongest argument for BAK centers on EPS Growth, Debt/Equity, Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bull Case : DOW

The strongest argument for DOW centers on Price/Book, EPS Growth, PEG Ratio. Revenue growth of 13.0% demonstrates continued momentum. PEG of 0.54 suggests the stock is reasonably priced for its growth.

Bear Case : BAK

The primary concerns for BAK are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : DOW

The primary concerns for DOW are Debt/Equity, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

BAK profiles as a growth stock while DOW is a turnaround play — different risk/reward profiles.

BAK carries more volatility with a beta of 0.77 — expect wider price swings.

BAK is growing revenue faster at 21.6% — sustainability is the question.

DOW generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

DOW scores higher overall (65/100 vs 48/100) and 13.0% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Braskem SA Class A

BASIC MATERIALS · CHEMICALS · USA

Braskem SA produces and markets thermoplastic resins. The company is headquartered in Camaari, Brazil.

Dow Inc

BASIC MATERIALS · CHEMICALS · USA

Dow Inc. is an American commodity chemical company. The company is headquartered in Midland, Michigan.

Visit Website →

Want to dig deeper into these stocks?